­

About Joe Flynn

This author has not yet filled in any details.
So far Joe Flynn has created 9 blog entries.

Bioanalytical Systems to Release Second Quarter Fiscal 2019 Results on Wednesday, May 15, 2019

CORRECTED PRESS RELEASE: BASi Acquires the Smithers Avanza Toxicology Services Business Unit to Support Growing Toxicology Business and Broaden Scientific Talent

BASi Acquires the Smithers Avanza Toxicology Services Business Unit

WEST LAFAYETTE, Ind., May 01, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc., (NASDAQ:BASI) (“BASi” or the “Company”) today announced its acquisition of the Smithers Avanza Toxicology Services business unit, a contract research organization (CRO) located in Gaithersburg, Maryland, which specializes in general toxicology, vaccine safety and developmental and reproductive toxicology (DART) studies, in support of pharmaceutical and chemical industry [...]

BASi Appoints Joe Flynn as Chief Commercial Officer

WEST LAFAYETTE, Ind., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce that Joe Flynn has been appointed as Chief Commercial Officer of the Company, effective as of February 21, 2019. Mr. Flynn will be responsible for leading sales and marketing efforts across BASi’s three sites located [...]

BASi Appoints Senior Contract Research Executive, D. Thomas Oakley, as Chief Operating Officer

WEST LAFAYETTE, Ind., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce that D. Thomas “Tom” Oakley has been appointed as Chief Operating Officer of the Company, effective as of February 11, 2019. Mr. Oakley will be responsible for leading operations among BASi’s three sites located in [...]

BASi Elects Entrepreneur, Who Has Led BASi Turnaround and Recent Growth, as President and Chief Executive Officer and a Director

WEST LAFAYETTE, Ind., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced the election of Robert Leasure, Jr., as President and Chief Executive Officer and as a director of the Company, effective as of January 12, 2019. Since September of 2016, Mr. Leasure has worked closely with the Company’s [...]

BASi Announces Appointment of John E. Sagartz to Board of Directors

WEST LAFAYETTE, IN, July 9, 2018 -- Bioanalytical Systems, Inc. (NASDAQ:BASI) has announced that its Board of Directors agreed unanimously on July 2, 2018, to appoint John E. Sagartz, DVM, PhD, DACVP, as a director. “We’re delighted to welcome John to our board,” said Dr. Gregory C. Davis, BASi’s Chairman of the Board. “For several [...]

BASi and Seventh Wave Laboratories Combine Operations to Provide Broader Solutions and Greater Scientific Expertise to Clients

WEST LAFAYETTE, IN, July 2, 2018 -- Bioanalytical Systems, Inc. (NASDAQ:BASI) and Seventh Wave Laboratories, LLC, today announced that they have signed an asset purchase agreement (APA) joining operations to provide broader solutions and greater scientific expertise to clients. BASi provides contract research services and niche instrumentation to the life sciences industry, primarily in drug [...]

Pathology Expertise Expands Again at Seventh Wave

Maryland Heights, MO – Seventh Wave Laboratories, LLC (www.7thwavelabs.com) announces that Judit Markovits, DVM, PhD, Diplomat ACVP, Fellow IATP has joined the firm to support their growing portfolio of clients.   Prior to Seventh Wave Dr. Markovits held an appointment at Houston Methodist Research Institute, where, she was responsible for providing pathology support in translational research.  [...]

Seventh Wave Laboratories

  • *=required
  • This field is for validation purposes and should be left unchanged.

X

Seventh Wave Laboratories

  • *=required
  • This field is for validation purposes and should be left unchanged.

X

Seventh Wave Laboratories

  • *=required
  • This field is for validation purposes and should be left unchanged.

X

Seventh Wave Laboratories

  • *=required
  • This field is for validation purposes and should be left unchanged.
X

Seventh Wave Laboratories

  • *=required
  • This field is for validation purposes and should be left unchanged.

X